Pernille Ravn - Concepedia

Author

Pernille Ravn

Also Known As

P Ravn, P. Ravn, PERNILLE RAVN, Penille Ravn, Pernille Ravn, Ravn, Pernille, Ravn, Pernille; id_orcid 0000-0001-8752-1121

182

Publications

6.1K

Citations

H-Index

112

Concepts

All Affiliations

Odense University Hospital Center for Clinical & Basic Research University of Southern Denmark Nottingham City Hospital Merck & Co., Inc., Rahway, NJ, USA (United States)

About

Pernille Ravn is an author at Odense University Hospital specializing in medicine, women's health, and osteoporosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	47	2.7K
2	Health Sciences	11	12	769
3	Education	1	1	29
4	Language Studies	1	1	211
5	Law	1	1	64

Pernille Ravn

Publications

5.5K

Citations

H-Index

Page 1

	Year	Citations
Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age David Hosking, Clair E.D. Chilvers, Claus Christiansen, New England Journal of Medicine	1998	487
Low Body Mass Index Is an Important Risk Factor for Low Bone Mass and Increased Bone Loss in Early Postmenopausal Women Pernille Ravn, Giovanni Cizza, N. H. Bjarnason, Journal of Bone and Mineral Research	1999	450
Prevention of Bone Loss With Alendronate in Postmenopausal Women Under 60 Years of Age David Hosking, Clair Chilvers, Claus Christiansen, Obstetrical & Gynecological Survey Literary TheoryClair E. D.GynecologyHistorical ScholarshipOsteoporosis	1998	211
Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study Yu Z. Bagger, László B. Tankó, Peter Alexandersen, Bone Bone DiseaseBone HealthHormone Replacement TreatmentOrthopaedic SurgeryGynecology	2004	186
Alendronate and Estrogen–Progestin in the Long-Term Prevention of Bone Loss: Four-Year Results from the Early Postmenopausal Intervention Cohort Study: A Randomized, Controlled Trial Pernille Ravn, Marianne Bidstrup, Richard D. Wasnich, Annals of Internal Medicine	1999	186
Total and regional body-composition changes in early postmenopausal women: age-related or menopause-related? Q Wang, Christian Hassager, Pernille Ravn, American Journal of Clinical Nutrition ObesityBody CompositionAgingPhysiologyGynecology	1994	163
The effect on bone mass and bone markers of different doses of ibandronate: A new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: A 1-year, randomized, double-blind, placebo-controlled dose-finding study Pernille Ravn, B. Clemmesen, B.J. Riis, Bone Bone MarkersOrthopaedicsBone MassBone DensityNew Bisphosphonate	1996	151
Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women Pernille Ravn, B. Clemmesen, Claus Christiansen Bone Bone DiseaseBiochemical MarkersBone HealthPhysiologyGynecology	1999	148
Monitoring of Alendronate Treatment and Prediction of Effect on Bone Mass by Biochemical Markers in the Early Postmenopausal Intervention Cohort Study<sup>1</sup> Pernille Ravn, D. J. Hosking, Desmond Thompson, The Journal of Clinical Endocrinology & Metabolism	1999	145
Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides Stephan Christgau, Christian Rosenquist, Peter Alexandersen, Clinical Chemistry Creatinine ExcretionDermatologyOsteoporosisOrthopaedic SurgeryBone Disease	1998	145

Page 1